US Edition33 Articles
33 Articles
InsideNoVA.com
Rheumatoid Arthritis On The Rise Worldwide, AI-Powered Study Estimates
Key Takeaways
AI-powered study shows surge in global rheumatoid arthritis since 1980, revealing local hotspots
The most comprehensive analysis of rheumatoid arthritis data to date reveals that demographic changes and uneven health infrastructure have exacerbated the rheumatoid arthritis burden since 1980 and shows global disparities on a granular level.
Barcelona – The selective IL-23 inhibitor guselkumab can effectively slow the progression of structural joint damage in people with active psoriatic arthritis (PsA). Researchers from Providence Swedish Medical Center in Seattle reported this at the European Congress of Rheumatology (EULAR 2025) in Barcelona (Abstract LB0010). In PsA, there is...
Methotrexate Use Linked to Lower Infection Risk in Early RA
TOPLINE: In patients with early rheumatoid arthritis (RA), methotrexate-based strategies were associated with a lower risk for serious infections compared with strategies using other conventional synthetic disease-modifying antirheumatic drugs (csDMARDs). Increasing age, smoking, and comorbidities were identified as important predictors of an increased risk for serious infections. METHODOLOGY: Researchers conducted an observational cohort study …
Coverage Details
Bias Distribution
- 39% of the sources lean Left
To view factuality data please Upgrade to Premium
